Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma

Clinical trial NCT02034123 · TERMINATED

Trial details

NCT number: NCT02034123
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Small Cell

Start date: 2014-02-04
Primary completion: 2017-04-18
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.